Povidone Iodine and Cesarean Section Wound Infections
Information source: Assiut University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Wound Infections
Intervention: Povidone Iodine 10% vand cesarean section wound infections (Drug); Povidone Iodine 7.5% vand cesarean section wound infections (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Assiut University
Summary
The aim of this randomized clinical trial is to compare the efficiency of hand scrubbing by
Povidone-Iodine solution 10% over 7. 5% concentration in decreasing post-cesarean section
wound infections & compare side effects of both agents.
Clinical Details
Official title: Povidone Iodine 10% Versus 7.5% Hand Scrub and Cesarean Section Wound Infections: A Randomized Trial
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Primary outcome: The difference of incidence of surgical site infection between both groups
Secondary outcome: The difference in the side effects between both groups e.g. dermatitis
Detailed description:
For centuries, hand washing with soap and water has been considered the main approach for
personal hygiene. In the community, hand hygiene has been known to prevent infectious
diseases and to decrease the burden of disease. Currently, hand hygiene is considered the
most important measure for preventing the spread of pathogens in health-care settings.
There are multiple agents used for surgical hand scrubbing as alcohol, chlorhexidine,
iodine/iodophors, para-chloro-meta-xylenol & triclosan. Ideally, the optimum antiseptic used
for scrub should have broad spectrum of activity, persistent effect & fast acting.
Unfortunately most studies evaluating surgical scrub antiseptics have focused on measuring
hand bacterial colony counts. No randomized clinical trials have evaluated the impact of
surgical scrub choice on surgical site infection risk & proven its efficiency.
Eligibility
Minimum age: 18 Years.
Maximum age: 40 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- elective caesarian section (CS)
Exclusion Criteria:
- diabetes,
- immuno-compromised patients
Locations and Contacts
Women Health Hospital - Assiut university, Assiut 71111, Egypt
Additional Information
Starting date: January 2012
Last updated: October 3, 2012
|
